Farallon Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $11.4M | Hold |
|
|||||
|
2019
Q4 | $25M | Buy |
|
|||||
|
2019
Q3 | $23.9M | Buy |
|
|||||
|
2019
Q2 | $23M | Sell |
|
|||||
|
2019
Q1 | $25.7M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $13.2M | Buy |
|
|||||
|
2017
Q2 | $10.6M | Sell |
|
|||||
|
2017
Q1 | $9.98M | Buy |
|
|||||
|
2016
Q4 | $2.75M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $5.97M | Buy |
|
|||||
|
2015
Q2 | $7.92M | Hold |
|
|||||
|
2015
Q1 | $9.73M | Buy |
|
|||||
|
2014
Q4 | $1.62M | Hold |
|
|||||
|
2014
Q3 | $1.18M | Hold |
|
|||||
|
2014
Q2 | $1.39M | Hold |
|
|||||
|
2014
Q1 | $1.93M | Hold |
|
|||||
|
2013
Q4 | $1.86M | Buy |
|
|||||
|
2013
Q3 | $2.67M | Sell |
|
|||||
|
2013
Q2 | $3.22M | Buy |
|